Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ORCHESTRA BIOMED HOLDINGS INC.

Orchestra BioMed Holdings Inc. (NASDAQ: OBIO)
Listen to this Section


$3.96
+0.0950 ( +2.46% ) 107.0K

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Market Data


Open $3.96
Previous Close $3.86
Volume 107.0K
Market Cap $231.14M
Day Range $3.80 - $4.00
52 Week Range $2.20 - $5.42
Shares Outstanding 59.88M
Change % +2.46%
Net Change ▲ 0.0950
Insider Ownership -0.35%
Exchange NASDAQ
SectorHealthcare
IndustryMedicinal Chemicals and Botanical Products
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 473,695.00

Date Type Amount Purchased Purchaser
2025-09-19 Buy 1000.00 Aryeh Jason
2025-08-25 Buy 2000.00 Taylor Andrew Lawrence
2025-08-25 Buy 5760.00 Fain Eric S
2025-08-25 Buy 6000.00 Hochman David P
2025-08-25 Buy 3000.00 Sherman Darren
2025-08-06 Buy 3636363.00 RTW INVESTMENTS, LP
2025-08-05 Buy 700000.00 PERCEPTIVE ADVISORS LLC
2025-08-04 Buy 20000.00 Hochman David P
2025-05-01 Buy 49900.00 RTW INVESTMENTS, LP
2025-04-29 Buy 50000.00 RTW INVESTMENTS, LP

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy